Pseudomonas aeruginosa and antibiotic resistance;Pseudomonas aeruginosa et résistance aux antibiotiques

Revue Francophone des Laboratoires

Volumn 2011, Issue 435, 2011, Pages 49-62

  Mérens, Audrey ^a   Delacour, Hervé ^a   Plésiat, Patrick ^b   Cavallo, Jean Didier ^c   Jeannot, Katy ^b  

^a HÔPITAL D'INSTRUCTION DES ARMÉES BÉGIN   (France)

^b Hospitalier Universitaire 3   (France)

^c Ecole du Val de Grace   (France)

Author keywords

antibiogram; antibiotics; Pseudomonas aeruginosa; resistance

Indexed keywords

EID: 84055218875     PISSN: 1773035X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-035X(11)71102-9     Document Type: Article

References (71)

1. H. Nikaido Transport through the outer membrane of bacteria Methods Enzymol 125 1986 265 278 (Pubitemid 16072643)
2. H. Hachler, P. Santanam, and F.H. Kayser Sequence and characterization of a novel chromosomal aminoglycoside phosphotransferase gene, aph (3')-IIb, in Pseudomonas aeruginosa Antimicrob Agents Chemother 40 1996 1254 1256
3. D.M. Livermore Beta-lactamases in laboratory and clinical resistance Clin Microbiol Rev 8 1995 557 584
4. D. Girlich, T. Naas, and P. Nordmann Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa Antimicrob Agents Chemother 48 2004 2043 2048 (Pubitemid 38691595)
5. K.F. Kong, S.R. Jayawardena, and S.D. Indulkar Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of Amp C and PoxB beta-lactamases, proteases, quorum sensing, and other virulence factors Antimicrob Agents Chemother 49 2005 4567 4575 (Pubitemid 41552586)
6. K. Poole Efflux-mediated antimicrobial resistance J Antimicrob Chemother 56 2005 20 51 (Pubitemid 41418335)
7. X.Z. Li, H. Nikaido, and K. Poole Role of Mex A-Mex B-Opr M in antibiotic efflux in Pseudomonas aeruginosa Antimicrob Agents Chemother 39 1995 1948 1953
8. J.R. Aires, T. Kohler, H. Nikaido, and P. Plésiat Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides Antimicrob Agents Chemother 43 1999 2624 2628 (Pubitemid 29519539)
9. K. Jeannot, M.L. Sobel, F. El Garch, K. Poole, and P. Plésiat Induction of the Mex XY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction J Bacteriol 187 2005 5341 5346 (Pubitemid 41022953)
10. A.D. Shawn, W. Ferris, K. Ramotar, K. Vandemheen, F. Chan, and R. Saginur Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis J. Clin. Microbiol 40 2002 4172 4179 (Pubitemid 35285808)
11. Jacoby G. Bacteria, INC ed, vol (1986). Academic Press, Orlando, Florida.
12. H.W. Stokes, and R.M. Hall A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons Mol Microbiol 3 1989 1669 1683 (Pubitemid 20023246)
13. R.P. Ambler The structure of B-lactamases. Philosophical transactions of the Royal Society of London. Series B Biological Sciences 289 1980 321 331
14. W.H. Zhao, and Z.Q. Hu Beta lactamases identified in clinical isolates of Pseudomonas aeruginosa Crit Rev in Microbiol 36 2010 245 258
15. D.M. Livermore Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34 2002 634 640 (Pubitemid 34165326)
16. J.D. Cavallo, F. Leblanc, R. Fabre, and A. Fourticq-Esqueoute GESPA Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study Pathol Biol 48 2000 472 477 (Pubitemid 30470525)
17. D. Hocquet, P. Plésiat, B. Dehecq, P. Mariotte, D. Talon, and X. Bertrand ONERBA. Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistance Pseudomonas aeruginosa strains in France Antimicrob Agents Chemother 54 2010 3512 3515
18. P. Nordmann, E. Ronco, and T. Naas Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa Antimicrob Agents Chemother 37 1993 962 969 (Pubitemid 23141304)
19. C. De Champs, C. Chanal, and D. Sirot Frequency and diversity of class A extended-spectrum of beta-lactamases in hospitals of the Auvergne. France: a 2 year prospective study J Antimicrob Chemother 54 2004 634 639 (Pubitemid 39263905)
20. T. Naas, and P. Nordmann OXA-type beta-lactamases Current Pharm Design 5 1999 865 879
21. L. Poirel, T. Naas, and P. Nordmann Diversity, epidemiology, and genetics of class D B-lactamases Antimicrob Agents Chemother 54 2010 24 38
22. D. Hocquet, B. Dehecq, X. Bertrand, and P. Plésiat Strain-tailored double disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa J Clin Microbiol 49 2011 2262 2265
23. M. Watanabe, S. Lyobe, M. Inoue, and S. Mitsuhashi Transferable imipenem resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 35 1991 147 151
24. T. Qu, J. Zhang, and J. Wang Evaluation of phenotypic tests for detection of metallo-beta-lactamase producing Pseudomonas aeruginosa strains in China J Clin Microbiol 47 2009 1136 1142
25. J. Trias, and H. Nikaido Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa Antimicrob Agents Chemother 34 1990 52 57 (Pubitemid 20019963)
26. S. Sakyo, H. Tomita, K. Tanimoto, S. Fujimoto, and Y. Ike Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa J Antibiot 59 2006 220 228 (Pubitemid 43854733)
27. D. Hocquet, P. Berthelot, and M. Roussel-Delvallez Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections Antimicrob Agents Chemother 51 2007 3531 3536 (Pubitemid 47519340)
28. C. Llanes, D. Hocquet, and C. Vogne Clinical strains of Pseudomonas aeruginosa overproducing Mex AB-Opr M and Mex XY efflux pumps simultaneously Antimicrob Agents Chemother 48 2004 1797 1802 (Pubitemid 38544391)
29. M.L. Sobel, G.A. Mc Kay, and K. Poole Contribution of the Mex XY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates Antimicrob Agents Chemother 47 2003 3202 3207 (Pubitemid 37229579)
30. N. Masuda, E. Sakagawa, and S. Ohya Substrate specificities of Mex AB-Opr M, Mex CD-Opr J, and Mex XY-Opr M efflux pumps in Pseudomonas aeruginosa Antimicrob Agents Chemother 44 2000 3322 3327 (Pubitemid 33009490)
31. N. Gotoh, H. Tsujimoto, and M. Tsuda Characterization of the Mex C-Mex D-Opr J multidrug efflux system in mex A-mex B-opr M mutants of Pseudomonas aeruginosa Antimicrob Agents Chemother 42 1998 1938 1943 (Pubitemid 28363073)
32. T. Köhler, M. Michéa Hamzehpour, and U. Henze Characterization of Mex E-Mex F-Opr N, a positively regulated multidrug efflux system of Pseudomonas aeruginosa Mol Microbiol 23 1997 345 354 (Pubitemid 27049187)
33. S. Magnet, and J.S. Blanchard Molecular insights into aminoglycoside action and resistance Chem Rev 105 2005 477 498
34. K. Poole Aminoglycoside resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 49 2005 479 487 (Pubitemid 40175650)
35. Y. Doi, and Y. Arakawa 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides Clin Infect Dis 45 2007 88 94 (Pubitemid 46984623)
36. K. Yokoyama, Y. Doi, and Yamane Acquisition of 16S r RNA methylase gene in Pseudomonas aeruginosa Lancet 362 2003 1888 1893 (Pubitemid 37518504)
37. Y. Doi, D. de Oliveira Garcia, J. Adams, and D.L. Paterson Coproduction of novel 16S r RNA methylase Rmt D and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil Antimicrob Agents Chemother 51 2007 852 856 (Pubitemid 46355266)
38. P. Bogaerts, M. Galimand, and C. Bauraing Emergence of Arm A and Rmt B aminoglycoside resistance 16S r RNA methylases in Belgium J Antimicrob Chemother 59 2007 459 464 (Pubitemid 47073451)
39. Y. Doi, K. Yokoyama, and K. Yamane Plasmid-mediated 16S r RNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides Antimicrob Agents Chemother 48 2004 491 496 (Pubitemid 38141707)
40. J. Wachino, K. Yamane, and K. Shibayama Novel plasmid-mediated 16S r RNA methylase, Rmt C, found in a Proteus mirabilis isolate demonstrating extraordinary high-level resistance against various aminoglycosides Antimicrob Agents Chemother 50 2006 178 184 (Pubitemid 43042919)
41. T. Akasaka, M. Tanaka, A. Yamaguchi, and K. Sato Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance Antimicrob Agents Chemother 45 2001 2263 2268 (Pubitemid 32664465)
42. J.K. Lee, Y.S. Lee, Y.K. Park, and B.S. Kim Alterations in the Gyr A and Gyr B subunits of topoisomerase II and the Par C and Par E subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa Int J Antimicrob Agents 25 2005 290 295 (Pubitemid 40387273)
43. J. Kriengkauykiat, E. Porter, O. Lomovskaya, and A. Wong-Beringer Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 49 2005 565 570 (Pubitemid 40175663)
44. C. Muller, P. Plésiat, and K. Jeannot A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and B-lactams in Pseudomonas aeruginosa Antimicrob Agents Chemother 55 2001 1211 1221
45. Cavallo JD, Fabre R. Pseudomonas aeruginosa: antibiogramme aux bêta-lactamines. EMC (Elsevier Masson SAS), Biologie clinique, 90-05-0247, 2004.
46. Comité de l'antibiogramme de la Société franaise de microbiologie. Recommandations 2011, 68 pages.(http://www.sfm-microbiologie.org) .
47. ® Rev Fr Lab 307 1998 65 69 (Pubitemid 128677022)
48. European committee on antimicrobial susceptibility testing. Disk diffusion test methodology, 2010(http://www.eucast.org).
49. L.F. Joyce, J. Downes, K. Stockman, and J.H. Andrew Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa J Clin Microbiol 30 10 1992 2709 2713
50. S.M. Moskowitz, E. Garber, and Y. Chen Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia J Antimicrob Chemother 65 2010 1416 1423
51. J.D. Cavallo, and A. Mérens Pseudomonas aeruginosa et bêta-lactamines l're de l'Europe Pathol Biol 56 2008 435 438
52. A. Mazzariol, M. Aldegheri, M. Ligozzi, G. Lo Cascio, R. Koncan, and R. Fontana Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance J Clin Microbiol 46 6 2008 2095 2098 (Pubitemid 351831852)
53. S. Juretschko, V.J. Labombardi, S.A. Lerner, P.C. Schreckenberger Pseudomonas AST Study group. Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, Micro Scan Walk Away, Vitek, and Vitek 2) J Clin Microbiol 45 4 2007 1339 1342 (Pubitemid 46626512)
54. H.S. Sader, T.R. Fritsche, and R.N. Jones Accuracy of three automated systems (Micro Scan Walk Away, Vitek, and Vitek 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents J Clin Microbiol 44 3 2006 1101 1104
55. C.D. Steward, J.M. Mohammed, J.M. Swenson, S.A. Stocker, P.P. Williams, and R.P. Gaynes Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates J Clin Microbiol 41 1 2003 351 358 (Pubitemid 36098599)
56. C.C. Sanders, M. Peyret, and E.S. Moland Ability of the Vitek 2 advanced expert system to identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa J Clin Microbiol 38 2 2000 570 574 (Pubitemid 30082643)
57. E. Torres, R. Villanueva, and G. Bou Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa J Med Microbiol 58 Pt 5 2009 625 629
58. C. Gagliotti, M. Sarti, and C. Sabia Accuracy of automated and manual systems for susceptibility testing of Pseudomonas aeruginosa to piperacillin and piperacillin-tazobactam New Microbiol 34 1 2011 97 99
59. Groupe d'étude de la résistance de Pseudomonas aeruginosa aux bêta-lactamines (GERPB) Évolution de la résistance aux antibiotiques de Pseudomonas aeruginosa en France de 1994 1998 Lett Infectiol 15 2000 18 23
60. J.D. Cavallo, D. Hocquet, P. Plésiat, R. Fabre, M. Roussel-Delvallez on behalf of GERPA Susceptibility of Pseudomonas aeruginosa to antimicrobials; a 2004 French multicentre hospital study J Antimicrob Chemother 59 2007 1021 1024 (Pubitemid 47073379)
61. G. Valenza, B. Jospeh, and J. Elias First survey of metallo-B-lactamase in clinical isolates of Pseudomonas aeruginosa in a German university hospital Antimicrob Agents Chemother 54 2010 3493 3497
62. W. Mansour, L. Poirel, and D. Bettaieb Metallo-beta-lactamase producing Pseudomonas aeruginosa isolates in Tunisia Diag Microb Inf Dis 64 2009 458 461
63. S. Pounaras, M. Manniati, and E. Petinaki Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-B-lactamase gene variants bla VIM-2 and bla VIM-4 J Antimicrob Chemother 51 2003 1405 1414
64. V. Dubois, C. Arpin, and V. Dupart Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres) J Antimicrob Chemother 62 2 2008 316 323 (Pubitemid 351984774)
65. M.D. Obritsch, D.N. Fish, and R. Mac Laren National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care units patients form 1993-2002 Antimicrob Agents Chemother 48 2004 4606 4610 (Pubitemid 39577660)
66. S.R. Lockhart, M.A. Abramson, and S.E. Beekmann Antimicrobial resistance among Gram negative bacilli causing infections in intensive care units patients in the United States between 1993 and 2004 J Clin Microbiol 45 2007 3352 3359 (Pubitemid 47585661)
67. D.M. Livermore, R. Hope, and G. Brick Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram negative bacteria from bacteraemias in the United Kingdom and Ireland, 2001-2006 J Antimicrob Chemother 62 Suppl2 2008 ii55 ii63
68. V.H. Tam, K.T. Chang, and K. Abdelraouf Prevalence, resistance and susceptibility of multidrug resistant bloodstream isolates of Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 1160 1164
69. E. Drenkard, and F.M. Ausubel Pseudomonas biofilm formation and antimicrobial resistance are linked to phenotypic variations Nature 416 2002 740 743 (Pubitemid 34429150)
70. D.T. Kenna, C.J. Doherty, and J. Foweraker Hypermutability in environmental Pseudomonas aeruginosa and populations causing pulmonary infections in individuals with cystic fibrosis Microbiology 153 2007 1852 1859 (Pubitemid 46952515)
71. th European congress of clinical microbiology and infectious diseases, Helsinki, Finland, 16-18 may 2009, P 1505.